Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedWellAI's gross profit for the
three
months ended in Mar. 2026 was $0.15 Mil. MedWellAI's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $0.55 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. MedWellAI's gross profit for the
three
months ended in Mar. 2026 was $0.15 Mil. MedWellAI's Revenue for the
three
months ended in Mar. 2026 was $0.62 Mil. Therefore, MedWellAI's Gross Margin % for the quarter that ended in Mar. 2026 was 23.42%.
MedWellAI had a gross margin of 23.42% for the quarter that ended in Mar. 2026 => Competition eroding margins
During the past 13 years, the highestGross Margin % of MedWellAI was 98.66%. The lowest was -260.22%. And the median was 30.11%.
MedWellAI (OTCPK:MWAI) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
MedWellAI had a gross margin of 23.42% for the quarter that ended in Mar. 2026 => Competition eroding margins
MedWellAI Gross Profit Related Terms
MedWellAI Gross Profit Historical Data
* Premium members only.
The historical data trend for MedWellAI's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MWAI vs IPST, BTMCQ, LMFA: Gross Profit Comparison
For the Capital Markets subindustry, MedWellAI's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedWellAI Gross Profit vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, MedWellAI's Gross Profit distribution charts can be found below:
* The bar in red indicates where MedWellAI's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.55 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
MedWellAI (MWAI) has a Gross Profit of $0.55 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on MedWellAI and its competitors.
Is MedWellAI's Gross Profit too high?
MedWellAI's current Gross Profit is $0.55 Mil. Overall, MedWellAI has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does MedWellAI's Gross Profit compare to IPST and BTMCQ?
MedWellAI's Gross Profit of $0.55 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Capital Markets company?
A good Gross Profit depends on the Capital Markets industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on MedWellAI and its competitors. MedWellAI's current Gross Profit is $0.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedWellAI stock overvalued right now?
MedWellAI (MWAI) has a current Gross Profit of $0.55 Mil. The current Gross Profit is $0.55 Mil. MedWellAI's overall GF Score™ is 1/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For MedWellAI (MWAI), the current Gross Profit is $0.55 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedWellAI Inc is a holding company focused on AI-driven healthcare and wellness solutions, offering a B2B platform for GLP medications with real-time inventory and provider support. The company operates as a single operating segment, focusing on acquiring, launching, and operating companies in the rapidly growing health and wellness sector.
1GF Score
Get the complete analysis for MWAI
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MWAI has been successfully added to your 
